UK +44 (0)1223 491486      USA toll free 1-866 877 2185

About Catherine

This author has not yet filled in any details.
So far Catherine has created 18 blog entries.

Qkine secures £1.5M series A funding from leading life science investors

Cambridge, UK 08 June 2020: Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications – today announced the successful closure of a £1.5M series A investment round to accelerate the global scale-up of its commercial operations and make key hires to its leadership team. The funding [...]

By |2020-12-08T16:09:36+00:00June 8th, 2020|news, press release|Comments Off on Qkine secures £1.5M series A funding from leading life science investors

Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio

Cambridge, UK 03 June 2019: Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications, has closed a further round of investment. The £550K funding round was led by Cambridge Enterprise and five angel investors – all of whom followed initial seed investments made in April 2018. Joining the original investors [...]

By |2020-08-25T09:06:13+00:00June 3rd, 2019|news, press release|Comments Off on Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio

Why quality is not just about purity – by Qkine founder Dr Marko Hyvönen

As a structural biologist, one will very quickly realise that protein not only needs to be pure, but it needs to be also homogeneous and the real proof of the protein’s quality is in its specific bioactivity. So,we clearly need different criteria for defining quality and that is what we do at Qkine.

By |2020-10-27T11:43:39+00:00August 7th, 2018|protein science, quality|Comments Off on Why quality is not just about purity – by Qkine founder Dr Marko Hyvönen

So what does the “i” in iteams mean?

Running for over a decade, the iteams programme partners multi-disciplinary teams of PhD students and postdocs with inventors from the University of Cambridge.  As we are a recent spin-out from the academic laboratory of our scientific founder Marko Hyvonen, we have had the pleasure of working with an iteam over the last months. The [...]

By |2020-08-25T09:22:33+00:00June 6th, 2018|news|Comments Off on So what does the “i” in iteams mean?

Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK

We were delighted to be awarded Innovate UK funding to address issues of quality and availability of growth factors for use in organoid technologies. The Qkine R&D team are applying a combination of protein expression, refolding optimisation and structure-guided protein engineering to improve the biological properties and quality of proteins such as R-spondins, TGFβ1, members of the BMP and FGF family proteins.

By |2020-08-25T09:50:27+00:00May 8th, 2018|news, organoid news, protein engineering|Comments Off on Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK

Qkine backed by Cambridge Enterprise and a quintet of angels

University of Cambridge spin-out Qkine has closed its seed investment round supported by Cambridge Enterprise, the commercialisation arm of the University, and a team of five angels led by Jim Warwick. The amount is undisclosed. Qkine is a specialist manufacturer of proteins that are used for control of stem cell growth and differentiation. The [...]

By |2020-08-25T10:00:53+00:00April 23rd, 2018|news, press release|Comments Off on Qkine backed by Cambridge Enterprise and a quintet of angels

Title

Go to Top